Safety and Performance of the Semical Adhesion Barrier Gel for Prevention of Intra-uterine Adhesion

Inclusion Criteria: * Female patients aged 18 and over * Patients who were treated with operative hysteroscopy for intrauterine pathology (endometrial polips, myomas with uterine cavity deformation, uterine septa, intrauterine adhesion, ovarian cyst, endometrial cyst, etc.) * Patients who had undergone operative hysteroscopy at least 30 days and at most 6 months ago * Patients who had second-look office hysteroscopy at least once after an operative hysteroscopy Exclusion Criteria: * Children and adolescents under 18 years of age * Having a body weight of more than 100 kg * Surgeries complicated by excessive bleeding; estimated blood loss of more than 100 cc * Surgeries complicated with uterine perforation * Presence of uncontrolled diabetes, coagulation disorders, and other severe chronic disorders * Presence of malignant tumor or diagnosis of cancer, presence of uterovaginal prolapse * Concomitant peritoneal grafting or tubal implantation * Concomitant intrauterine device implantation * Patients without second-look hysteroscopy According to the GDPR and clinical investigation legislation, written informed consent is not mandatory in retrospective studies as long as the patient's personal information is censored.